AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALGORAE PHARMACEUTICALS LTD

0.023

+0.0014.55%

Volume:74.23K

Turnover:1.58K

Market Cap:38.84M

PE:-46.09

High:0.023

Open:0.023

Low:0.021

Close:0.022

52wk High:0.024

52wk Low:0.005

Shares:1.69B

Float Shares:1.05B

Volume Ratio:0.07

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.000

EPS(LYR):0.000

ROE:-30.63%

ROA:-23.85%

PB:17.43

PE(LYR):-46.09

Loading ...

Overview Company News Filings

BRIEF-Algorae Pharmaceuticals Signs License & Supply Agreement With Cadila

Algorae Pharmaceuticals Ltd - Agreement to Launch 2 Generic Medicines for Cardiovascular & Metabolic Disorders in Australia & New Zealand

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Secures A$3 Million Debt Facility With Scotpac

Algorae Pharmaceuticals Ltd - Secures a$3 Mln Debt Facility With Scotpac

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-Loyalty Options Offer Open and Shareholder Letters

THOMSON REUTERS

INDIA STOCKS-India's Nifty 50 stock index poised to hit record high after 14 months

BRIEF-Algorae Pharmaceuticals Signs Distribution Agreement With Dr. Reddy's Laboratories

ASX Small-Cap Stocks to Watch

MT Newswires Live

Algorae Pharmaceuticals Ltd - Signs Distribution Agreement With DR. Reddy's Laboratories

THOMSON REUTERS

Algorae Pharmaceuticals - Agreement to Supply Chemotherapy Medicine Capecitabine Into Australian Market

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-Proposed Issue of Securities - 1AI

THOMSON REUTERS

Algorae Pharmaceuticals Ltd-Prospectus - Loyalty Options Offer

THOMSON REUTERS

Algorae Pharmaceuticals Driving Expansion with Innovation and Commercialisation

Algorae Pharmaceuticals Ltd-Quarterly Activities Report /Appendix 4C Cash Flow Statement

THOMSON REUTERS

BRIEF-Algorae Pharmaceuticals Signs Binding Term Sheet With Cadila Pharmaceuticals

Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership

Algorae Pharmaceuticals - Under Proposed Agreement, Co Will Launch Two Generic Medicines in Aunz Markets, Others

THOMSON REUTERS

Algorae Pharmaceuticals Appoints COO; Shares Up 10%

MT Newswires Live

Algorae Pharmaceuticals Ltd-Algorae Appoints Chief Operating Officer, Mr David Gulland

THOMSON REUTERS

Algorae Pharmaceuticals Enters Licensing Agreement with Indian Manufacturer for Launch of Generic Oncology Medicines in Australia, New Zealand

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/1AI.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"1AI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","market":"AU","secType":"STK","nameCN":"ALGORAE PHARMACEUTICALS LTD","latestPrice":0.023,"timestamp":1770689422955,"preClose":0.022,"halted":0,"volume":74232,"delay":0,"changeRate":0.0454545454545455,"nameEN":"ALGORAE PHARMACEUTICALS LTD","floatShares":1046585658,"shares":1688759058,"eps":-0.000499,"marketStatus":"Trading","change":0.001,"latestTime":"02-10 13:28:59 AEDT","open":0.023,"high":0.023,"low":0.021,"amount":1584,"amplitude":0.090909,"askPrice":0.023,"askSize":397970,"bidPrice":0.022,"bidSize":86060,"shortable":3,"etf":0,"ttmEps":-0.000499,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.06616,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","floatShares":1046585658,"roa":"-23.85%","roe":"-30.63%","lyrEps":-0.000499,"volumeRatio":0.06616,"shares":1688759058,"dividePrice":0,"high":0.023,"amplitude":0.090909,"preClose":0.022,"low":0.021,"week52Low":0.005,"pbRate":"17.43","psRate":"275.37","week52High":0.024,"institutionHeld":0,"latestPrice":0.023,"committee":-0.644402,"eps":-0.000499,"divideRate":0,"volume":74232,"delay":0,"ttmEps":-0.000499,"open":0.023,"prevYearClose":0.014,"prevWeekClose":0.023,"prevMonthClose":0.021,"prevQuarterClose":0.014,"fiveDayClose":0.021,"twentyDayClose":0.015,"sixtyDayClose":0.009,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AI.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AI.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610503625","title":"BRIEF-Algorae Pharmaceuticals Signs License & Supply Agreement With Cadila","url":"https://stock-news.laohu8.com/highlight/detail?id=2610503625","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610503625?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:47","pubTimestamp":1770590879,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Signs License & Supply Agreement With CadilaFeb 9  - Algorae Pharmaceuticals Ltd 1AI.AX:ALGORAE SIGNS LICENSE AND SUPPLY AGREEMENT WITH CADILASIGNS LICENSE AND SUPPLY AGREEMENT WITH CADILAAGREEMENT TO LAUNCH 2 GENERIC MEDICINES FOR CARDIOVASCULAR & METABOLIC DISORDERS IN AUSTRALIA & NEW ZEALANDFurther company coverage: 1AI.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260208:nFWN3Z21LL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2610508219","title":"Algorae Pharmaceuticals Ltd - Agreement to Launch 2 Generic Medicines for Cardiovascular & Metabolic Disorders in Australia & New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2610508219","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610508219?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:02","pubTimestamp":1770588176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260208:nFWN3Z21LL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2605125729","title":"BRIEF-Algorae Pharmaceuticals Secures A$3 Million Debt Facility With Scotpac","url":"https://stock-news.laohu8.com/highlight/detail?id=2605125729","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605125729?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:37","pubTimestamp":1768959477,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Secures A$3 Million Debt Facility With ScotpacJan 21 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:SECURES A$3 MILLION DEBT FACILITY WITH SCOTPACFurther company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2605977144","title":"Algorae Pharmaceuticals Ltd - Secures a$3 Mln Debt Facility With Scotpac","url":"https://stock-news.laohu8.com/highlight/detail?id=2605977144","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605977144?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:01","pubTimestamp":1768946479,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2588705140","title":"Algorae Pharmaceuticals Ltd-Loyalty Options Offer Open and Shareholder Letters","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588705140?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:04","pubTimestamp":1764626680,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUE9G2MGM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2586290360","title":"INDIA STOCKS-India's Nifty 50 stock index poised to hit record high after 14 months","url":"https://stock-news.laohu8.com/highlight/detail?id=2586290360","media":"Reuters","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586290360?lang=en_us&edition=fundamental","pubTime":"2025-11-27 10:26","pubTimestamp":1764210403,"startTime":"0","endTime":"0","summary":"INDIA STOCKS-India's Nifty 50 stock index poised to hit record high after 14 monthsAdds Stocks to Watch after paragraph 11","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nL4N3X3062:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2586299307","title":"BRIEF-Algorae Pharmaceuticals Signs Distribution Agreement With Dr. Reddy's Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299307","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299307?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:03","pubTimestamp":1764201793,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Signs Distribution Agreement With Dr. Reddy's LaboratoriesNov 27 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:SIGNS DISTRIBUTION AGREEMENT WITH DR. REDDY'S LABORATORIES","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nFWN3X2132:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2586729626","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2586729626","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586729626?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:48","pubTimestamp":1764200892,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.HeraMED (ASX:HMD)HeraMED secured a pilot agreement to deploy its HeraCARE digital mat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PFE.AU","IG6.AU","XKO.AU","BK7023","BK7067","BK7104","1AI.AU","BK7007","AA2.AU","HMD.AU","BK7095","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2586729388","title":"Algorae Pharmaceuticals Ltd - Signs Distribution Agreement With DR. Reddy's Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=2586729388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586729388?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:00","pubTimestamp":1764194435,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X2132:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"2586293889","title":"Algorae Pharmaceuticals -  Agreement to Supply Chemotherapy Medicine Capecitabine Into Australian Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2586293889","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586293889?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:00","pubTimestamp":1764194435,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X2132:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2584699386","title":"Algorae Pharmaceuticals Ltd-Proposed Issue of Securities - 1AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2584699386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584699386?lang=en_us&edition=fundamental","pubTime":"2025-11-17 06:30","pubTimestamp":1763332219,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251116:nTUE7YH8V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2584696755","title":"Algorae Pharmaceuticals Ltd-Prospectus - Loyalty Options Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584696755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584696755?lang=en_us&edition=fundamental","pubTime":"2025-11-17 06:12","pubTimestamp":1763331175,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251116:nTUE4BSYNG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2579913421","title":"Algorae Pharmaceuticals Driving Expansion with Innovation and Commercialisation","url":"https://stock-news.laohu8.com/highlight/detail?id=2579913421","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579913421?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:01","pubTimestamp":1761688878,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals has reported a period of significant expansion as it broadens its operations to include complementary commercial activities.In the three months to end September, the company advanced its dual-track strategy of AI-driven innovation and pharmaceutical commercialisation, securing two landmark deals to expand its presence across Australia and New Zealand.Algorae also advanced its proprietary AI drug discovery platform and therapeutic pipeline.Negotiations with Cadila to finalise a definitive licencing and supply agreement are advancing, with regulatory submissions to follow.The partnership represents a step forward in establishing a sustainable revenue base through Algorae’s wholly-owned subsidiary AlgoraeRx, and followed the execution of anexclusive licencing deal with Sakar Healthcarethat will enable the launch of five oncology generics across the region.Collectively, the Cadila and Sakar partnerships expand Algorae’s portfolio to seven initial medicines, reinforc","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Driving-Expansion-Innovation-Commercialisation.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Driving-Expansion-Innovation-Commercialisation.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/algorae-pharmaceuticals-driving-expansion-innovation-commercialisation/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/algorae-pharmaceuticals-driving-expansion-innovation-commercialisation/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK4543","BK4587","AI","BK7067","BK4023","BK4585","BK4588","BK4528","BK4551","1AI.AU"],"gpt_icon":0},{"id":"2578467102","title":"Algorae Pharmaceuticals Ltd-Quarterly Activities Report /Appendix 4C Cash Flow Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2578467102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578467102?lang=en_us&edition=fundamental","pubTime":"2025-10-28 06:00","pubTimestamp":1761602448,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUE86D8KC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"2576888258","title":"BRIEF-Algorae Pharmaceuticals Signs Binding Term Sheet With Cadila Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2576888258","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576888258?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:31","pubTimestamp":1760923903,"startTime":"0","endTime":"0","summary":"BRIEF-Algorae Pharmaceuticals Signs Binding Term Sheet With Cadila PharmaceuticalsOct 20 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:SIGNS BINDING TERM SHEET WITH CADILA PHARMACEUTICALSALGORAE SIGN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3W000C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"2576600257","title":"Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2576600257","media":"Small Caps","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576600257?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:56","pubTimestamp":1760918195,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals and private Indian company Cadila Pharmaceuticals have entered into a licence and supply agreement covering two new generic medicines for the Australian and New Zealand markets.The agreement will formalise an operational framework for the partnership and will see Algorae commence planning for Therapeutic Goods Administration  registration to enable commercialisation of the products, which will target key therapeutic areas including cardiovascular and metabolic disorders.Cadila operates manufacturing facilities in the US, UK, European Union, and Australia, and its products are distributed in over 100 countries, supported by a workforce of more than 9,000 professionals and a research and development division comprising more than 350 scientists.Algorae chief commercial officer Vishal Shah said the agreement would expand Algorae’s commercial footprint into new regions.“This deal represents an important step in executing our commercial strategy and expanding our prod","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["1AI.AU","BK7001","XKO.AU","XJO.AU","BK7103","EBO.AU","XAO.AU","BK4213","BK7067","TGA","TGA.AU"],"gpt_icon":0},{"id":"2576800962","title":"Algorae Pharmaceuticals - Under Proposed Agreement, Co Will Launch Two Generic Medicines in Aunz Markets, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2576800962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576800962?lang=en_us&edition=fundamental","pubTime":"2025-10-20 06:00","pubTimestamp":1760911200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251019:nFWN3W000C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"2575605287","title":"Algorae Pharmaceuticals Appoints COO; Shares Up 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575605287","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575605287?lang=en_us&edition=fundamental","pubTime":"2025-10-16 11:05","pubTimestamp":1760583920,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals (ASX:1AI) appointed David Gulland as chief operating officer, effective March 2026, according to a Thursday filing with the Australian bourse.The company's shares rose 10% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK4198","LU2272731600.USD","BK4585","BK4588","1AI.AU","COO","GB00BDT5M118.USD","LU2272731782.SGD","LU2211815571.USD","XAO.AU","XJO.AU","LU1992135399.USD","LU1992135472.HKD","XKO.AU"],"gpt_icon":0},{"id":"2575752075","title":"Algorae Pharmaceuticals Ltd-Algorae Appoints Chief Operating Officer, Mr David Gulland","url":"https://stock-news.laohu8.com/highlight/detail?id=2575752075","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575752075?lang=en_us&edition=fundamental","pubTime":"2025-10-16 06:03","pubTimestamp":1760565815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUEB4WYSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"2569226759","title":"Algorae Pharmaceuticals Enters Licensing Agreement with Indian Manufacturer for Launch of Generic Oncology Medicines in Australia, New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2569226759","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569226759?lang=en_us&edition=fundamental","pubTime":"2025-09-23 08:18","pubTimestamp":1758586726,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals (ASX:1AI) entered into an exclusive licensing deal with Indian pharmaceutical firm Sakar Healthcare to launch five generic oncology medicines into the Australian and New Zealan","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ50G.NZ","XKO.AU","XAO.AU","1AI.AU","T10G.NZ","MDCO","XJO.AU","BK7067","NZ20C.NZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}